Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

Matthieu Million (1) , Audrey Giraud-Gatineau (2) , Jean-Christophe Lagier (1) , Philippe Parola (2) , Philippe Gautret (2) , Didier Raoult (1)

1 MEPHI - Microbes évolution phylogénie et infections
2 VITROME - Vecteurs - Infections tropicales et méditerranéennes

Domaines: Bactériologie; Virologie; Parasitologie; Cardiologie et système cardiovasculaire; Maladies émergentes; Maladies infectieuses

Matthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, et al.. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Medicine and Infectious Disease, 2021, 39, pp.101954. ⟨10.1016/j.tmaid.2020.101954⟩. ⟨hal-03211439⟩